Stewart-Jackson Pharmacal is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.
Trademark Applications
Trademark applications show the products and services that Stewart-Jackson Pharmacal is developing and marketing.
Stewart-Jackson Pharmacal doesn't have any recent trademark applications, indicating Stewart-Jackson Pharmacal is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
EXOTUSS COUGH SUPPRESSANT, DECONGESTANT, ANTIHISTAMINE, AND ANTITUSSIVE
07/19/2005
RESPEX PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF RHINITIS, SINUSITIS, AND THE COMMON COLD
04/11/2005
UTA PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF URINARY TRACT INFECTION
10/06/2004
See all trademarks and details in the Full Report.
Market Share of Stewart-Jackson Pharmacal's Largest Competitors
A competitive analysis shows these companies are in the same general field as Stewart-Jackson Pharmacal, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Stewart-Jackson Pharmacal.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Stewart-Jackson Pharmacal and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.